Drug intelligence / Profile preview

cavity cleanser

Development stage: Unknown
Lead developer: BISCO
Modality: Small Molecules
Administration: Topical, Dental

Overview

Cavity Cleanser is a dental product consisting of a 2% solution of chlorhexidine digluconate, designed for cleansing and moistening or re-wetting cavity preparations during restorative dental procedures. Its primary use is to remove debris and bacteria from prepared tooth cavities after preparation or etching, prior to sealing the dentinal tubules. This process may help decrease post-operative sensitivity and can enhance bond strength when used as a re-wetting agent on overly dried dentin before bonding. The solution is clear, odorless, and has a pH between 5.4–6.5[1][2][3][5][7].

Brand names: Cavity Cleanser

Beyond the preview

Go deeper on cavity cleanser.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on cavity cleanser.

Explore the full profile